Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2013 - 2026)

Agios Pharmaceuticals (AGIO) has 14 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q2 2026.

• Quarterly Asset Utilization Ratio rose 217.51% year-over-year to 0.09 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.09 (up 217.51% YoY) and the FY2025 annual result came in at 0.04, up 30.02% from the prior year.
• Asset Utilization Ratio grew to 0.09 in Q2 2026, from 0.05 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q2 2026 to a low of 0.0 in Q1 2022.
• A 5-year average of 0.03 and a median of 0.02 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 99.14% — and 2023, when it soared 2552.53%.
• Tracing AGIO's Asset Utilization Ratio over 5 years: stood at 0.01 in 2022, then soared by 134.35% to 0.03 in 2023, then slipped by 23.42% to 0.02 in 2024, then surged by 90.63% to 0.04 in 2025, then soared by 112.93% to 0.09 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.09 (Q2 2026), 0.05 (Q1 2026), and 0.04 (Q4 2025), per Business Quant data.